JULIA KASPER: Open Payments
NPI 1972875292 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 41 payments from 16 companies in 2025. Trend: 2023 $2,013 · 2024 $1,925 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $242 |
| ABBVIE INC. | 7 | $131 |
| PFIZER INC. | 5 | $99 |
| Abbott Laboratories | 4 | $77 |
| Exact Sciences Corporation | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: Ozempic, VRAYLAR, FREESTYLE LIBRE 3, UBRELVY, TRELEGY ELLIPTA, NURTEC ODT, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
